title: Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.
authors.affiliation: Assistance Publique-Hôpitaux de Paris, CEREDIH, Centre de Référence Déficits Immunitaires Héréditaires, Hôpital Necker-Enfants Malades, Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker Pasteur, Paris, France; Institut Imagine, Université Sorbonne Paris Cité, Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Noel
authors.forename: Nizar
authors.initials: N
authors.lastname: Mahlaoui
authors.forename: Stéphane
authors.initials: S
authors.lastname: Blanche
authors.forename: Felipe
authors.initials: F
authors.lastname: Suarez
authors.forename: Hélène
authors.initials: H
authors.lastname: Coignard-Biehler
authors.forename: Isabelle
authors.initials: I
authors.lastname: Durieu
authors.forename: Philippe
authors.initials: P
authors.lastname: Godeberge
authors.forename: Harry
authors.initials: H
authors.lastname: Sokol
authors.forename: Emilie
authors.initials: E
authors.lastname: Catherinot
authors.forename: Sylvain
authors.initials: S
authors.lastname: Poiree
authors.forename: Hugo
authors.initials: H
authors.lastname: Chapdelaine
authors.forename: Bertrand
authors.initials: B
authors.lastname: Dunogue
authors.forename: Christine
authors.initials: C
authors.lastname: Bodemer
authors.forename: Marc
authors.initials: M
authors.lastname: Lecuit
authors.forename: Alain
authors.initials: A
authors.lastname: Fischer
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006105:Granulomatous Disease, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007223:Infant; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D008297:Male; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide